Barclays downgrades Fresenius Medical Care to underweight, cuts target to €35
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Barclays downgraded dialysis group Fresenius Medical Care (ETR:FMEG) to "underweight" from "equal weight" and lowered its price target to €35 from €44.50, saying reimbursement pressures, weak volume growth and inflation will hurt earnings. Still guessing which…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe downgrade and lower target weigh on the stock, with estimates below consensus.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Barclays cut its target from €44.50 to €35.
- 02The new target implies 17.3% downside from the November 5 close of €42.32.
- 03Barclays forecasts adjusted EBIT to decline an average of 3% a year from 2025 to 2028.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets